Immunogenicity and Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Healthy Volunteers Aged 2 Years and Above

NCT04278248 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1940

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumonia, Pneumococcal

Interventions

BIOLOGICAL: 23-Valent Pneumococcal Polysaccharide Vaccine

Sponsor

Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd